18 September 2019 - More than 950,000 Belgians have responded to a couple seeking €1.9m ($2m; £1.7m) to cover the cost of their baby's life-saving treatment.
Nine-month-old Pia, who has spinal muscular atrophy and lives in Antwerp, requires the drug Zolgensma, which has not been approved for use in Europe but is available in the US.
Her parents have now raised enough for a single course of treatment.